Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin for Alcohol Withdrawal
NCT04232800Phase 2Unknown
- Sponsor
- Oregon Health & Science University
- Start
- Dec 2021
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of riboflavin in alcohol withdrawal syndrome (AWS), sponsored by Oregon Health & Science University. Status: unknown.
02
Drugs
riboflavin
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT04232800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04232800.